Daunorubicin hydrochloride is primarily used in the treatment of various types of cancer, particularly acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). It works by interfering with the DNA in cancer cells, preventing them from dividing and growing. This chemotherapeutic agent is often administered intravenously as part of combination therapy to enhance its effectiveness. Additionally, it is sometimes used in the treatment of other cancers, such as neuroblastoma and certain types of lymphoma. Due to its potent nature, careful monitoring is required to manage potential side effects, including heart toxicity and bone marrow suppression.